Open Access Open Access  Restricted Access Subscription or Fee Access

Clinical and demographic characteristics of cervical cancer patients presenting at Parirenyatwa Hospital, Zimbabwe

Oppah Kuguyo, Nomsa Tsikai, Senelisiwe Chipo Muradzikwa, Kudakwashe Mhandire, Charles Nhachi, Thulani Magwali, Mugove G Madziyire, Alice Matimba, Collet Dandara


Cervical cancer is the leading cause of cancer deaths in women in Africa, predominately due to late diagnosis. This study aims to identify risk factors, potential prognostic indicators, and optimal treatment modalities for Zimbabwean cervical cancer patients. Medical records for 1063 cervical cancer patients were reviewed for sociodemographic, clinical, treatment, and response data. All data were analysed using SPSS version 25. More than half of the cohort was pre-menopausal (63%) with low (2%) history of cervical cancer screening. Schistosoma ova were observed in 2.4% of the tumour specimens. More than 50% were diagnosed at stage 3 and later, with a high frequency of comorbidities (~68%). This study highlights a need for improving screening education and uptake in Zimbabwe. Moreover, the current data provides a dataset for understanding cervical cancer pathogenesis and treatment responses in an African cohort. (Afr J Reprod Health 2021; 25[6]: 99-109).

Full Text:



World Health Organisation. Cancer: Fact sheets. 2019. [Accessed online via:] Accessed on 22 October 2019.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J. and Jemal A. Global cancer statistics. CA Cancer J. Clin 2015; 65: 87–108.

Mboumba Bouassa RS, Prazuck T, Lethu T, Meye JF and Belec L. Cervical cancer in sub-Saharan Africa: an emerging preventable disease associated with oncogenic human papillomavirus. Med Sante Trop 2017; 27(1): 16-22.

Johnson LG, Armstrong A, Joyce CM, Teitelman AM and Buttenheim AM. Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: A systematic review. Implementation Science 2018; 13(1): 28-46.

Jedy-Agba E, Joko WY, Liu B, Buziba NG, Borok M, Korir A, Masamba L, Manraj SS, Finesse A, Wabinga H, Somdyala N and Parkin DM. Trends in cervical cancer incidence in sub-Saharan Africa. BJC 2020; 123(1): 148-154.

Johnson LG, Armstrong A, Joyce CM, Teitelman AM and Buttenheim AM. Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: A systematic review. Implementation Science 2018; 13(1): 28-46.

Chokunonga E, Borok MZ, Chirenje MZ, Makunike-Mutasa R, Ndlovhu N, Nyakabau AM and Vuma S. Pattern of cancer in Zimbabwe: Zimbabwe national cancer registry 2014 annual report. Ministry of Health and Child Care. 2015 [Accessed online via:] Accessed on: 7 July 2020.

Kuguyo O, Matimba A, Tsikai N, Magwali T, Madziyire M, Gidiri M, Dandara C and Nhachi C. Cervical cancer in Zimbabwe: a situations analysis. Pan Afr Med J 2017; 27(215): 1-18.

Kassa RT. Risk factors associated with precancerous cervical lesion among women screened at Marie Stops Ethiopia, Adama town, Ethiopia 2017: a case control study. BMC Res Notes 2018; 11(1): 145-150.

Haileselassie W, Mirgissa K, ArayaSellasie M, Mulugeta T and Labisso WL. Challenges and opportunities in

cancer diagnosis in Ethiopia: in depth exploration of practitioners’ view. International Journal of Current Research 2017; 9(7): 54662-54668.

Gopal S, Wood WA, Lee SJ, Shea TC, Naresh KN, Kazembe PN, Casper C, Hesseling PB and Mitsuyasu RT. Meeting the challenge of hematologic malignancies in sub-Saharan Africa. Blood 2012; 119(22): 5078–5087.

Black E and Richmond R. Prevention of cervical cancer in sub-Saharan Africa: the advantages and challenges of HPV vaccination. Vaccines (Basel) 2018; 6(3): 61-69.

Cao L, Wen H, Feng Z, Han X and Wu X. Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer. International Journal of Gynecological Cancer 2019; 29(8):1244-125.

Jain R, Nigam RK, Malik R and Jain P. Clinicopathological presentation of cervical cancer in Bhopal. Indian Journal of Medical and Paediatric Oncology 2019; 40(5): 33-37.;year=2019;volume=40;issue=5;spage=33;epage=37;aulast=Jain.

Raju K, CV R and SR S. Clinicopathological correlation of invasive squamous cell carcinoma of uterine cervix: A cross-sectional study. Biomed Res. Ther. 2019; 6(11): 3443-3451.

Ikechebelu JI, Onyiaorah IV, Ugboaja JO, Anyiam DCD and Eleje GD. Clinicopathological analysis of cervical cancer seen in a tertiary health facility in Nnewi, South-East Nigeria. Journal of Obstetrics and Gynaecology 2010; 30(3).

Afroj S, Banu MA, Sultana S, Jahan R, Rahman S and Begun N. Clinicopathological profile of cervical cancer patients attending in a specialised. J Dhaka Med Coll 2017; 26(2): 117-21.

Shruthi PS, Kalyani R, Kai LJ and Narayanaswamy M. Clinicopathological correlation of cervical carcinoma: a tertiary based study. Asian Pac J Cancer Prev 2014; 15(4): 1671-4.

Kaur A, Chawla A, Manjari M. Incidence and Clinicopathological correlation of cervical cancer in a tertiary care center: a 5-year retrospective study. Curr Trends Diagn Treat 2019; 3(2): 64-67.

Rana MK, Singh K, Mahajan MK and Rana APS. Clinicopathological profile of cervical carcinoma: an experience of tertiary care cancer centre. Asian Pacific Journal of Cancer Care 2019; 4(3): 83-86.

Kasule J. The pattern of gynaecological malignancy in Zimbabwe. East Afr Med J 1989; 66(6): 393-9.

Chirenje MZ, Rusakaniko S, Akino V and Mlingo M. A review of cervical cancer patients presenting in Harare and Parirenyatwa Hospitals in 1998. Centr Afr J Med 2000; 46(10): 264-7.

Mushosho EY, Ndlovu N, Engel-Hills P and Wyrley-Birch B. Presentation patterns of invasive cancer of the cervix: results from Parirenyatwa Oncology and Radiotherapy Centre, Harare, Zimbabwe 1998-2010. Centr Afr J Med 2011;57(9-12): 43-9.

Ndlovu N and Kambarami R. Factors associated with tumour stage at presentation in invasive cervical cancer. Centr Afr J Med 2003; 49(9-10): 107-11

Chirenje ZM. HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol 2005;19(2): 269-76.

Einstein MH, Ndlovu N, Lee J, Stier EA, Kotzen J, Garg M,

Whitney K, Lensing SY, Tunmet M, Kadzatsa W, Palefsky J and Krown SE. Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium. Gynecol Oncol 2019; 153(1): 20-25 .

Nyamhunga A, Ndlovu N, Kadzatsa W, Morse GD and

Maponga CC. Chemoradiation in Stage IIIB cancer of the uterine cervix: A review of the Zimbabwean experience. JCO Global Oncology 2020; 6: 1554-1564.

Kuguyo O, Misi FD, Chibonda S, Matimba A, Nhachi C and Tsikai N. Pain management strategies among cervical cancer patients in Zimbabwe. Future Medicine: Pain Management 2021. [Accessed online via:]. Accessed on 18 August 2021.

Nejo YT, Olaleye DO and Odaibo GN. Prevalence and risk factors for genital human papillomavirus infections among women in Southwest Nigeria. Arch Basic Appl Med 2018; 6(1): 105-112.

Chokunonga E, Ramanakumar AV, Nyakabau AM, Borok MZ, Chirenje M, Sankila R and Parkin MD. Survival of cervix cancer patients in Harare, Zimbabwe, 1995-1997. Int J Cancer 2004; 109: 274-277.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. Estimates of worldwide burden of cancer in 2009: Globocan 2008. Int J Cancer 2010; 127(12): 2893-917.

Human Papillomavirus Information for Cancer Organization. Information on HPV and cancer for South Africa. [Accessed online via:] Accessed on 22 March 2020.

Ferdous J, Begum SA, Ferdous NE, Nahar Q, Khatum SF and Khatun S. Presentation of invasive cervical cancer in Bangladesh. BSMMUJ 2013; 8(1): 29-32.

Kennedy NT, Ikechukwu D and Goddy B. Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria. Pan Afr Med J 2016; 23:85.

Nessa A, Chowdhury SB, Fatima P, Sharif M and Azad AK. Cervical cancer screening program in Bangladesh. Bangladesh Journal of Obstetrics and Gynaecology 2020; 33(1): 63-73.

Kerry MLD, Mallick L and Allen C. Sexual and reproductive health in early and later adolescence: DHS data on youth age 10-19. DHS Comparative reports No. 45. [Accessed online via:] Accessed on 18 January 2021.

Bobdey S, Sathwara J, Jain A and Balasubramaniam G. Burden of cervical cancer and role of screening in India. Ind J Med 2016; 37(4): 278-85.

Ghosh M, Rodriguez-Garcia M and Wira CR. The immune system in menopause: pros and cons of hormone therapy. J Steroid Biochem Mol Biol 2013; [Accessed via:] Accessed on: 25 October

Parkin DM, Vizcaino AP, Skinner ME and Ndhlovu A. Cancer patterns and risk factors in the African population of southwestern Zimbabwe, 1963-1977. Cancer Epidemiol Biomarkers Prev 1994; 3(7): 537-547.

Fadahunsi OO, Omoniyi-Esan GO, Banjo AA, Esimai OA, Osiagwu D, Clement F, Adeteye OV, Bejide RA and Iyiola S. Prevalence of High Risk oncogenic HPV types in cervical smears of women attending well women clinic in Ile-Ife. Gynaecol Obstet 2013; 3(6):1000185.

Roser M. Fertility Rate. 2019 [Accessed online via:]. Accessed on 5 Dec 2019.

Darre T, Aboubakari AS, N’Bortche BK, Bassowa A and Napo-Koura G. Association of Schistosomiasis with cervical cancer in Togo: the consequence of this association. Pathol Oncol Res 2019; 25(2): 807-808.

Mutengo MM, Mudenda V, Mwansa JC, Kaonga K, Sianongo S and Wamulume H. Presence of Schistomiasis in genital biopsies from patients at the university teaching Hospital in Lusaka, Zambia. Med J Zambia 2010; 26(3): 114–118.

Pillay P, Lieshout L, Taylor M, Sebitloane M, Zulu SG, Kleppa E, Roald B and Kjetland EF. Cervical cytology as a diagnostic tool for female genital schistosomiasis: correlation to cervical atypic and schistosoma polymerase chain raction. Cytojournal 2016; 13(10).

Toller A, Scopin AC, Apfei V, Pringezi KCK, Tso FK, Focchi GRA, Speck N and Ribalta J. An interesting finding in the uterine cervix: Schistosoma hematobium calcified eggs. Autos Case Rep 2015; 5(2): 41-44.

Savardekar LS, Balaiah D and Mali BN. Association of Schistosoma haematobium and human papillomavirus in cervical cancer: a case report. Acta Cytol 2010; 54(2): 205-8.

Mbah MLN, Poolman EM, Drain PK, Coffee MP, van der Werf MJ and Galvani AP. HIV and Schistosoma haematobium prevalences correlate in sub-Saharan Africa. Trop Med Int Health 2013; 18(10):1174-1179.

Norseth HM, Ndhlovu PD, Kleppa E, Randrianasolo BS, Jourdan PM, Roald B, Holmen SD, Gundersen SG, Bagratee J, Onsrud M and Kjetland EF. The colposcopic atlas of schistosomiasis in the lower female genital tract based on studies in Malawi, Zimbabwe, Madagascar and South Africa. PLoS Negl Trop Dis 2014; 8(11): e3229.

AVERT organization. HIV and AIDS in Zimbabwe. 2018. [Accessed online via:] Accessed on: 21 Nov 2018.

Min KJ, Lee JK, Lee S and Kim MK. Alcohol consumption and viral load are synergistically associated with CIN1. PLoS One 2013; 8(8): e72142.

Cao S, Yang C, Gan Y and Lu Z. The Health Effects of Passive Smoking: An Overview of Systematic Reviews Based on Observational Epidemiological Evidence. PLoS One 2015; 10(10): e0139907.

Kjetland EF, Ndhlovu PD, Mduluza T, Deschooleester V, Midzi N, Gomo E, Gwanzura L, Mason PR, Vermorken JB, Friis H, Gundersen SG and Baay MF. The effects of genital schistosoma haematobium on human papillomavirus and the development of cervical neoplasia after five years in a Zimbabwean population. Eur J Gynaecol Oncol 2010; 31(2): 169-73.

Martino JL and Vermund SH. Vaginal douching: evidence for risks or benefits to women’s health. Epidemiol Rev 2008; 24(2): 109-24.

Suwannarurk K, Bhamarapravatana K, Kheolamai P, Thaweekul Y, Mairaing K, Poomtavorn Y and

Pattaraararchachal J. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?. Asian Pac J Cancer Prev 2010; 11(5): 1397-401.

Gundrajakuppam L, Shanthi V and Rao NM. Clinicopathological correlation of cervical carcinoma by Pap smear. J Biosci Tech 2011; 2: 439-45.

Holman LL, Ran Y and Westin SN. Status of epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a cancer report. BMC Cancer 2015; 15: 728.

Rudek MA, Flexner C and Ambinder RF. Use of anti-neoplastic agents in cancer patients with HIV/AIDS. Lancet Oncol 2010; 12(9): 905-12.

Berretta M, Caraglia M, Martellotta F, Zappavigna S, Lombardi A, Fierro C, Atripaldi L, Muto T, Valente D, Paoli PD, Tirelli U and Francia RD. Drug-drug interactions based on pharmacogenetics profile between highly active antiretroviral therapy and anti-neoplastic chemotherapy in cancer patients with HIV infection. Front Pharmacol 2016; 7(71): 1-17.

Welz T, Wyen C and Hensel M. Drug interactions in the treatment of malignancy HIV-infected patients. Oncol Res Treat 2017; 40:120-7.

Xulu KR and Hosie MJ. HAART induced cell death in a cervical cancer cell line, HCS-2: a scanning electron microscopy study. J Microsc Ultrastruct 2017; 5(1): 39-48.

Pham PA and Flexner C. Emerging antiretroviral drugs interactions. Journal of antimicrobial chemotherapy 2010; 66(2): 235-9.

Makinson A, Pujol J, Moing VL, Peyriere H and Reynes J. Interactions between cytotoxic chemotherapy and antiretroviral treatment in human immune-deficiency virus-infected patients with lung cancer. Journal of Thoracic Oncology 2010; 5(4): 562-71.

Srivastava K, Paul S, Chufal KS, Shamsunder SD, Lal P, Pant MC, Bhatt M, Singh S and Gupta R. Concurrent chemoradiation versus radiotherapy alone in cervical carcinoma: A randomized phase III trial. Asia Pac J Clin Oncol 2013; 9(3): 349-356.

Amptoulach S and Tsavaris N. Neurotoxicity caused by the treatment with platinum analogues. Chemotherapy Research Practice 2011; 843019.

Smith EM, Pang H, Cirrincione C, Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 2013; 309(13): 1359–67.

Gupta R and Bhaskar A. Chemotherapy-induced peripheral neuropathic pain. BJA Education 2016; 16(4):114-119.

Staff NP, Grisold A, Grisold W and Windebank AJ. Chemotherapy-induced peripheral neuropathy: A current review. Ann Neurol 2017; 81(6): 772-761.

Zoodsma M, Sijmons RH, de Vries EGE and van der Zee AGJ. Familial cervical cancer: case reports, review and clinical implications. Hereditary Cancer in Clinical Practice 2004; 2(99).

Sijmons RH, Boonstra AE, Reefhuis J, Hordijk-Hos JM, de Walle HE, Oosterwijk JC, Cornel MC. Accuracy of family history of cancer: clinical genetic implications. Eur J Hum Genet 2000;

(3): 181-186.

Hemminki K, Dong C, Vaittinen P. Familial risks in cervical cancer: is there a hereditary component? Int J Cancer 1999; 82(6): 775-781.<775::AID-IJC1>3.0.CO;2-V.

Magnusson PK, Lichtenstein P, Gyllensten UB. Heritabiliy of cervical tumours. Int J Cancer 2000; 88(5): 698-701.<698::AID-IJC3>3.0.CO;2-J.

Andrews FJ, Linehan JJ, Melcher DH. Cervical carcinoma in both mother and daughter. Acta Cytol 1981; 25(1): 3-4.

Kiptoo S, Otieno G, Tonui P, Mwangi A, Orango O, Itsura P, Muthoka K, Oguda J, Rosen B, Loehrer P and Cu-Uvin S. Loss to follow-up in a cervical cancer screening and treatment program in western Kenya. JCO Glob Oncol 2018; 4(2):

Stausberg J, Koch D, Ingeberf J and Betzler M. Comparing paper-based with electronic patient records: lessons learned during a study on diagnosis and procedure codes. J Am Med Inform Assoc 2003;10(5): 470-477.


  • There are currently no refbacks.